小瓶适配器市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

根据 Global Market Insights, Inc. 的最新报告，2024 年全球小瓶转接器市场价值为 10 亿美元，预计将从 2025 年的 11 亿美元成长到 2034 年的 19 亿美元，复合年增长率为 6.5%。该行业的发展势头受到市场对安全药物无菌重建和疫苗接种的需求，以及减轻医院和临床环境中污染风险的需求的推动。

小瓶适配器可在转移和重建注射药物时实现「无针」操作，有助于提高安全性和效率，特别是在重症监护、肿瘤科和疫苗接种等关键环境中。

关键驱动因素：

1. 生物製剂和疫苗的使用日益增多：生物製剂数量的增加和疫苗接种计划的扩大增加了对安全、高效重组的需求。

2. 感染预防与安全问题：小瓶转接器提供无针、封闭系统的药物输送，防止针刺事故和微生物污染。

3. 简化医院和临床工作流程：这些产品使药物准备更加容易，节省时间并最大限度地减少药物错误。

4. 监管推动封闭系统转移装置 (CSTD)：全球建议使用 CSTD 进行癌症和危险药物处理，这正在加速小瓶适配器的采用。

关键参与者：

West Pharmaceutical Services、Thermo Fisher Scientific、Becton, Dickinson and Company 和 ICU Medical 等主要公司占据了 44.4% 的累积市场。

West 是国内领先的小瓶转接器供应商，2024 年的市占率为 21.2%。

主要挑战：

• 可扩展性：由于某些小瓶适配器可能不适合任何特定的小瓶或药物配方，因此在许多情况下，客製化解决方案必然会导致库存工作的复杂性。
• 规模经济/采购：初始产品投资和没有本地供应链可能会限制医疗系统采用和使用适配器解决方案的能力，尤其是在资源受限的环境中。
• 废弃物和环境议程：一次性塑胶适配器会产生医疗废弃物。一些製造商正在研究开发可回收材料适配器的可能性。

1. 依产品类型 - 一次性使用小瓶转接器

一次性药瓶适配器凭藉其更佳的感染控制、合规性以及在医院和实验室临床环境中的易用性，在2024年成为市场领导者。它们在化疗、免疫接种和重症监护药物製备方面享有优先使用权。

2. 尺寸 - 20mm，通用

20毫米的尺寸可普遍适用于肿瘤学、传染病和儿科相关的治疗领域。

3. 依材质分类－聚碳酸酯位居第一

2024 年，聚碳酸酯小瓶适配器将占据主导地位，因为它具有耐用性、耐化学性和透明度，可以在将药物从小瓶适配器转移到注射器的过程中进行目视检查。

4. 依最终用途 - 医院电力核心需求

2024 年，医院仍将是药瓶适配器的主要最终用途，因为此类机构需要无菌、经济高效的药物管理系统来满足大量患者的需求，尤其是在肿瘤科和传染病科。

5. 按地区划分－北美继续占据主导地位

北美继续主导全球药瓶适配器市场，其在医疗基础设施和先进药物输送系统方面投入了大量资金。封闭式转移装置 (CSTD) 的使用和感染预防措施的推广也进一步促进了该地区的成长。 2024 年，北美在全球药瓶适配器市场占据主导地位，这得益于慢性病患者的增加、高昂的医疗支出以及完善的医院基础设施。该地区还拥有许多知名的製药和生物技术公司，进一步推动了药瓶适配器在无菌药物製备中的应用。由于疫苗接种力度的加大以及预充式註射器和封闭式药物输送系统的广泛使用，美国继续成为药瓶适配器市场的主要贡献者。

一些主要的小瓶适配器市场参与者包括 B. Braun、Baxter International、Becton、Dickinson and Company、West Pharmaceutical Services、Yukon Medical、Thermo Fisher Scientific、ICU Medical、Helapet、Epic Medical、CODAN Medizinische Gerate、Miltenyi Biotec、EQUASHpet、Epic Medical、CODAN Medizinische Gerate、Miltenyi Biotec、EQUASHIELD 和 VYGON。

市场领导者正押注于产品创新、合作和监管审批，以保持竞争力。例如，West Pharmaceutical Services 不断扩展其药瓶适配器产品组合，以促进生物製剂的安全復溶。 Becton, Dickinson and Company 和 Baxter International 正在将药瓶适配器纳入其输液和预充式註射器平台，以最大程度地减少污染。此外，各公司也正在投资可持续材料/客製尺寸的转接器，以满足不同医院的需求和药品规格。

目录

第一章：方法论与范围

第 2 章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 慢性病盛行率不断上升
    • 提高对小瓶适配器优势的认识
    • 老年人口增加
  • 产业陷阱与挑战
    • 替代品的可用性
  • 市场机会
    • 生物製剂和生物相似药的扩张
    • 无针给药系统的需求不断成长
• 成长潜力分析
• 监管格局
• 技术格局
  • 当前的技术趋势
  • 新兴技术
  • 2024 年按产品类型分類的定价分析
  • 全球的
    • 一次性使用小瓶转接器
    • 多用途小瓶转接器
  • 北美洲
    • 一次性使用小瓶转接器
    • 多用途小瓶转接器
  • 欧洲
    • 一次性使用小瓶转接器
    • 多用途小瓶转接器
  • 亚太地区
    • 一次性使用小瓶转接器
    • 多用途小瓶转接器
  • 拉丁美洲
    • 一次性使用小瓶转接器
    • 多用途小瓶转接器
  • 多边环境协定
    • 一次性使用小瓶转接器
    • 多用途小瓶转接器
• 差距分析
• 波特的分析
• PESTEL分析
• 未来市场趋势
• 价值链分析

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
  • 全球的
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲和中东地区
• 竞争定位矩阵
• 主要市场参与者的竞争分析
• 关键进展
  • 併购
  • 伙伴关係与合作
  • 新产品类型发布
  • 扩张计划

第五章：市场估计与预测：依产品类型，2021 - 2034 年

• 主要趋势
• 一次性使用小瓶转接器
  • 通风小瓶转接器
  • 非通气小瓶转接器
• 多用途小瓶转接器
  • 通风小瓶转接器
  • 非通气小瓶转接器

第六章：市场估计与预测：依产品规模，2021 - 2034 年

• 主要趋势
• 13毫米
• 20毫米
• 其他产品尺寸

第七章：市场估计与预测：按材料，2021 - 2034 年

• 主要趋势
• 聚碳酸酯
• 硅酮
• 聚乙烯
• 其他材料

第八章：市场估计与预测：依最终用途，2021 - 2034 年

• 主要趋势
• 医院
• 门诊手术中心
• 其他最终用途

第九章：市场估计与预测：按地区，2021 - 2034

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十章：公司简介

• B. Braun
• Baxter International
• Becton, Dickinson and Company
• CODAN Medizinische Gerate
• Epic Medical
• EQUASHIELD
• Helapet
• ICU Medical
• Miltenyi Biotec
• Thermo Fisher Scientific
• VYGON
• West Pharmaceutical Services
• Yukon Medical

The global vial adaptors market was valued at USD 1 billion in 2024 and is projected to grow from USD 1.1 billion in 2025 to USD 1.9 billion by 2034, registering a CAGR of 6.5%, according to the latest report by Global Market Insights, Inc. The sector's momentum has been driven by market needs for safe drug sterile reconstitution and vaccinations, as well as a need to mitigate contamination risk in hospitals and clinical environments.

Vial adaptors help improve safety and efficiency by enabling 'needle-free' access when transferring and reconstituting injectable drugs, particularly in critical settings such as critical care, oncology, and vaccine administration.

Key Drivers:

1. Increasing use of biologics and vaccines: Increasing numbers of biologic drugs and expanding vaccination programs have increased demand for safe and efficient reconstitution.

2. Infection prevention and safety issues: Vial adaptors provide needle-free, closed-system medication delivery, preventing needlestick accidents and microbial contamination.

3. Streamlining hospital and clinical workflow: These products make drug preparation easier, saving time and minimizing drug errors.

4. Regulatory push to close-system transfer devices (CSTDs): Global recommendations for using CSTDs for cancer and hazardous drug handling are accelerating vial adaptor adoption.

Key Players:

Major players like West Pharmaceutical Services, Thermo Fisher Scientific, Becton, Dickinson and Company, and ICU Medical hold a cumulative market share of 44.4%.

West is the leading domestic vial adaptor supplier with 21.2% market share in 2024.

Key Challenges:

• Scalability:;As some vial adaptors may not fit any particular vial or drug formulation, in many instances, custom solutions would necessarily lead to complexities in inventory efforts.
• Economies of scale/Procurement:;Initial product investments and no local supply chains may limit the medical system's ability to adopt and use adaptor solutions, especially in resource constrained environments.
• Waste and environmental agenda:;The single-use plastic based adaptors contribute to medical waste.;Some manufacturers are investigating the potential to develop recyclable material-based adaptors.;

1. By Product Type - Single-Use Vial Adaptors Lead

Single-use vial adaptors were the market leader in 2024 due to their better infection control, regulatory compliance, and ease of use in hospitals and laboratory clinical settings. They are used in preference in chemotherapy, immunization, and critical care drug preparation.

2. Size - 20mm For Universal Application

A 20mm size offers universal applicability to therapy areas related to oncology, infectious diseases, and pediatrics.

3. Based on Material - Polycarbonate Contributes to 1ST Position

In 2024, polycarbonate based vial adaptors lead the way, based upon durability, chemical resistance, and transparency permitting visual inspection during the transfer of the drug from the vial adapter to the syringe.

4. By End Use - Hospitals Power Core Demand

Hospitals continued to be the major End Uses of vial adaptors in 2024, since such facilities need aseptic, cost-effective drug administration systems to meet high patient loads, particularly in oncology and infectious disease departments.

5. By Region - North America Continues to Dominate

North America continued to dominate the global market for vial adaptors with strong investments in healthcare infrastructure and advanced drug delivery systems. The usage of closed-system transfer devices (CSTDs) and promotion of infection prevention practices additionally enhance regional growth. North America dominated the world vial adaptors market in 2024, aided by increasing numbers of chronic diseases, high expenditure on healthcare, and sound hospital infrastructure. The region is also home to a number of prominent pharmaceutical and biotechnology companies, further driving the adoption of vial adaptors in sterile drug preparation. The US continues to be a dominant contributor because of growing vaccination efforts and extensive use of prefilled syringes and closed drug delivery systems.

Some of the major vial adaptors market players are B. Braun, Baxter International, Becton, Dickinson and Company, West Pharmaceutical Services, Yukon Medical, Thermo Fisher Scientific, ICU Medical, Helapet, Epic Medical, CODAN Medizinische Gerate, Miltenyi Biotec, EQUASHIELD, and VYGON.

Market leaders are placing bets on product innovation, collaborations, and regulatory clearances to remain competitive. An example of this is West Pharmaceutical Services, which continues to expand its portfolio of vial adaptors to facilitate safe reconstitution of biologics.;Becton, Dickinson and Company and Baxter International are incorporating vial adaptors into their infusion and prefilled syringe platforms to minimize contamination. Also, companies are spending money on sustainable materials/ adaptors of custom sizes to satisfy different hospital needs and drug formats.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product type trends
  • 2.2.3 Product size trends
  • 2.2.4 Material trends
  • 2.2.5 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of chronic conditions
    • 3.2.1.2 Rise in awareness regarding advantages of the vial adaptors
    • 3.2.1.3 Increase in geriatric population
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Availability of substitutes
  • 3.2.3 Market opportunities
    • 3.2.3.1 Expansion of biologics and biosimilars
    • 3.2.3.2 Growing demand for needle-free drug delivery systems
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 MEA
• 3.5 Technology landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Global vial adaptor market, by volume (Units), 2021 - 2034
  • 3.6.1 Pricing analysis, By product type, 2024
  • 3.6.2 Global
    • 3.6.2.1 Single-use vial adaptors
    • 3.6.2.2 Multi-use vial adaptors
  • 3.6.3 North America
    • 3.6.3.1 Single-use vial adaptors
    • 3.6.3.2 Multi-use vial adaptors
  • 3.6.4 Europe
    • 3.6.4.1 Single-use vial adaptors
    • 3.6.4.2 Multi-use vial adaptors
  • 3.6.5 Asia Pacific
    • 3.6.5.1 Single-use vial adaptors
    • 3.6.5.2 Multi-use vial adaptors
  • 3.6.6 Latin America
    • 3.6.6.1 Single-use vial adaptors
    • 3.6.6.2 Multi-use vial adaptors
  • 3.6.7 MEA
    • 3.6.7.1 Single-use vial adaptors
    • 3.6.7.2 Multi-use vial adaptors
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Future market trends
• 3.11 Value chain analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
  • 4.3.5 LAMEA
• 4.4 Competitive positioning matrix
• 4.5 Competitive analysis of major market players
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product type launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Single-use vial adaptors
  • 5.2.1 Vented vial adaptors
  • 5.2.2 Non-vented vial adaptors
• 5.3 Multi-use vial adaptors
  • 5.3.1 Vented vial adaptors
  • 5.3.2 Non-vented vial adaptors

Chapter 6 Market Estimates and Forecast, By Product Size, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 13 mm
• 6.3 20 mm
• 6.4 Other product sizes

Chapter 7 Market Estimates and Forecast, By Material, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Polycarbonate
• 7.3 Silicone
• 7.4 Polyethylene
• 7.5 Other materials

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgical centers
• 8.4 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 B. Braun
• 10.2 Baxter International
• 10.3 Becton, Dickinson and Company
• 10.4 CODAN Medizinische Gerate
• 10.5 Epic Medical
• 10.6 EQUASHIELD
• 10.7 Helapet
• 10.8 ICU Medical
• 10.9 Miltenyi Biotec
• 10.10 Thermo Fisher Scientific
• 10.11 VYGON
• 10.12 West Pharmaceutical Services
• 10.13 Yukon Medical